Molecular Diagnostics Markets: Global Analysis and Opportunity Evaluation 2016 - 2020
This new report gives a comprehensive and easy-to-review analysis of the molecular diagnostics market for the period 2016 -2020. The report provides key market information and identifies new and emerging opportunities across this growing field. Its findings enable suppliers to reduce costs, drive sales and compete more effectively in the global marketplace.
Laboratory Markets Limited has completed a comprehensive global market study of molecular diagnostics, covering established, recently developed and more specialised methods used in both clinical and clinical research settings. This market analysis reviewed 75,000 clinical and clinical research molecular studies across more than 23,000 clinical and research organisations, encompassing 13 global regions and 125 countries. This identified 12,500 molecular diagnostics laboratories, which were profiled as part of Molecular Diagnostics 2016. Details of these end-user organisations by name are provided as part of this report.
These new findings are the result of a detailed three-year market study by Laboratory Markets Limited, covering the period up until May 2016. These leading market data are combined and analysed alongside findings on the growth and costs of molecular diagnostics from five four other independent market studies, carried out by Laboratory Markets Limited. These five (separate) studies involved the participation of more than 1,700 molecular diagnostics end-users, details of which are also provided with this report.
The clinical and research molecular studies reviewed as part of Molecular Diagnostics 2016 were carried out by experienced molecular biology end-users. These end-users are important decision-makers in the selection and purchase of molecular diagnostics products and services and these 'real world' market data give in-depth information on the current and future use of molecular diagnostics, in addition to % growth, costs, trends and opportunities.
End-user organisations by name are identified in all key molecular diagnostics sectors and segments of this market study. Findings are provided as a PDF report, together with the full Molecular Diagnostics 2016 market database created and compiled during this extensive market study. The data provided enables molecular diagnostics suppliers to easily and rapidly identify, analyse and profile areas of the molecular diagnostics market that offer the greatest business opportunities to their own companies.
The extensive market database provided with the report augments the detailed market findings presented in the PDF report, allowing rapid and easy in-depth analysis across all molecular diagnostics markets. This database can be shared across all departments and subsidiaries of purchasing organisations.
These new study findings provide a considerable wealth of market information to suppliers in the molecular diagnostics and molecular biology fields. They assist suppliers in identify new molecular diagnostics market opportunities and give powerful strategic insights into new developments and applications.
Companies mentioned
A&A Biotechnology, AB ANALITICA, Abbott, Abcam, AccuGenomics, AdnaGen, AdvanDx, Affymetrix, Agendia, Agilent, Ameripath, Amoy Diagnostics, Amplisens, Analytik Jena, Apex, Applied BioCode, Applied BioSystem, Arcxis Biotechnologies, Argene, Inc (Biomerieux), Arrayit, Asuragen, Atlas Genetics, AutoGenomics, Axygen (Corning), Bayer, Beckman Coulter, Becton-Dickinson, Biocartis, Biocept, Biodynamics, Biodyne, Biofire, BioGenex, Biognost, BioGX, BioHelix, Bioline, Biomerieux, Biometra, Bioneer, Bio-Rad, bioTheranostics (AviaraDx), Biotools, Biozyme, Cancer Genetics, Caris Life Sciences, Ceeramtools, Cell Signaling Technology, Cell-marque, Cepheid, Chronix Biomedical, CIS Bioassays, Clarient, Clontech, Conda, Cooperative Diagnostics, Coris-Bio, Cytocell, Da An Gene, Dako (Agilent), DermTech, Diasorin, DNA Technology, ELITech Molecular, Empire Genomics, Enzynomics, Epicentre, Epigenomics, Eppendorf, ESCO, Euroclone, Eurofins, Eurogentec, Euroimmun, Experteem, Falcon Genomics, Fast track Diagnostics, Fermantas, Fermentas, Fisher Biotech, Fisher Scientific, Fluidigm, Focus Diagnostics, Foundation Medicine, GE Healthcare, Gen Probe, Genesearch, Geneworks, GenMark Diagnostics, Genomica, Gen-Probe, Gold Standard Diagnostics, Hain Life Science, Hemogenomics, Hologic, Hylabs, Idaho, IDEXX, IDVET, Illumina, INEP, Integrated Biotherapeutics, Integrated Data Technologies (IDT), IntelligentMDx, Interpath, Invitrogen, Ipsogen (Qiagen), IQuum, Kapa Biosystems, Kreatech Diagnostics, Lectinity, Leica, LGC, Life Technologies, LKB, Luminex, Macherey-Nagel, MDxHealth, Merck Millipore, Meridian Bioscience, Metabion, Millipore, MJ Research, Mobio, MolecularMD, MRC-Holland, MWG Biotech, Myriad Genetics, Nanosphere, NeoGenomics, New England Biolabs, Novagen, Novartis, Olerup SSP, Omega Bio-Tek, Optigene, Orion Genomics, Ortho-Clinical Diagnostics, OvaGene Oncology, Oxoid, Palex, Pathology, Perkin Elmer, Primer Design, PrimeraDx, Promega, Qiagen, Quanta Biosciences, Quidel, R-Biopharm Inc, Ribomed, Roche, Sacace Biotechnologies, Santacruz, Scientifix, Seegene, Seeplex, SensiGen, Serosep Ltd, Siemens, Sigma-Aldrich, Sigma-Genosys, SinaGen, Stratagene (Agilent), Synbiotics, Sysmex, Takara, Thermo Fisher, TiBMolBiol, Ventana (Roche), Vircell, Virion, vivantis, VWR, Zeiss, Zymo
Key Features
Enables suppliers to profile key areas of molecular diagnostics markets relating to their own products and services and provides qualified prospects by end-user organisation name 2) Analyses and ranks molecular diagnostics practices by country, organisation type, methods, diseases, clinical research areas, viruses, bacteria and others, helping suppliers to identify 'high opportunity' sectors relevant to their current molecular diagnostics products and future plans in these fields, supporting targeted marketing and reducing costs and risks 3) Provides key information in growing and developing areas of the molecular diagnostics market, helping suppliers focus resources on molecular diagnostics growth areas, supporting new sales opportunities in important market sectors 4) Helps suppliers to evolve and extend their own strategic visions, future plans and operational activities in the molecular diagnostics field 5) Enables suppliers to identify, analyse and rank end-user practices and needs and build new customer relationships in leading molecular diagnostics market sectors.
Laboratory Markets Limited has completed a comprehensive global market study of molecular diagnostics, covering established, recently developed and more specialised methods used in both clinical and clinical research settings. This market analysis reviewed 75,000 clinical and clinical research molecular studies across more than 23,000 clinical and research organisations, encompassing 13 global regions and 125 countries. This identified 12,500 molecular diagnostics laboratories, which were profiled as part of Molecular Diagnostics 2016. Details of these end-user organisations by name are provided as part of this report.
These new findings are the result of a detailed three-year market study by Laboratory Markets Limited, covering the period up until May 2016. These leading market data are combined and analysed alongside findings on the growth and costs of molecular diagnostics from five four other independent market studies, carried out by Laboratory Markets Limited. These five (separate) studies involved the participation of more than 1,700 molecular diagnostics end-users, details of which are also provided with this report.
The clinical and research molecular studies reviewed as part of Molecular Diagnostics 2016 were carried out by experienced molecular biology end-users. These end-users are important decision-makers in the selection and purchase of molecular diagnostics products and services and these 'real world' market data give in-depth information on the current and future use of molecular diagnostics, in addition to % growth, costs, trends and opportunities.
End-user organisations by name are identified in all key molecular diagnostics sectors and segments of this market study. Findings are provided as a PDF report, together with the full Molecular Diagnostics 2016 market database created and compiled during this extensive market study. The data provided enables molecular diagnostics suppliers to easily and rapidly identify, analyse and profile areas of the molecular diagnostics market that offer the greatest business opportunities to their own companies.
The extensive market database provided with the report augments the detailed market findings presented in the PDF report, allowing rapid and easy in-depth analysis across all molecular diagnostics markets. This database can be shared across all departments and subsidiaries of purchasing organisations.
These new study findings provide a considerable wealth of market information to suppliers in the molecular diagnostics and molecular biology fields. They assist suppliers in identify new molecular diagnostics market opportunities and give powerful strategic insights into new developments and applications.
Companies mentioned
A&A Biotechnology, AB ANALITICA, Abbott, Abcam, AccuGenomics, AdnaGen, AdvanDx, Affymetrix, Agendia, Agilent, Ameripath, Amoy Diagnostics, Amplisens, Analytik Jena, Apex, Applied BioCode, Applied BioSystem, Arcxis Biotechnologies, Argene, Inc (Biomerieux), Arrayit, Asuragen, Atlas Genetics, AutoGenomics, Axygen (Corning), Bayer, Beckman Coulter, Becton-Dickinson, Biocartis, Biocept, Biodynamics, Biodyne, Biofire, BioGenex, Biognost, BioGX, BioHelix, Bioline, Biomerieux, Biometra, Bioneer, Bio-Rad, bioTheranostics (AviaraDx), Biotools, Biozyme, Cancer Genetics, Caris Life Sciences, Ceeramtools, Cell Signaling Technology, Cell-marque, Cepheid, Chronix Biomedical, CIS Bioassays, Clarient, Clontech, Conda, Cooperative Diagnostics, Coris-Bio, Cytocell, Da An Gene, Dako (Agilent), DermTech, Diasorin, DNA Technology, ELITech Molecular, Empire Genomics, Enzynomics, Epicentre, Epigenomics, Eppendorf, ESCO, Euroclone, Eurofins, Eurogentec, Euroimmun, Experteem, Falcon Genomics, Fast track Diagnostics, Fermantas, Fermentas, Fisher Biotech, Fisher Scientific, Fluidigm, Focus Diagnostics, Foundation Medicine, GE Healthcare, Gen Probe, Genesearch, Geneworks, GenMark Diagnostics, Genomica, Gen-Probe, Gold Standard Diagnostics, Hain Life Science, Hemogenomics, Hologic, Hylabs, Idaho, IDEXX, IDVET, Illumina, INEP, Integrated Biotherapeutics, Integrated Data Technologies (IDT), IntelligentMDx, Interpath, Invitrogen, Ipsogen (Qiagen), IQuum, Kapa Biosystems, Kreatech Diagnostics, Lectinity, Leica, LGC, Life Technologies, LKB, Luminex, Macherey-Nagel, MDxHealth, Merck Millipore, Meridian Bioscience, Metabion, Millipore, MJ Research, Mobio, MolecularMD, MRC-Holland, MWG Biotech, Myriad Genetics, Nanosphere, NeoGenomics, New England Biolabs, Novagen, Novartis, Olerup SSP, Omega Bio-Tek, Optigene, Orion Genomics, Ortho-Clinical Diagnostics, OvaGene Oncology, Oxoid, Palex, Pathology, Perkin Elmer, Primer Design, PrimeraDx, Promega, Qiagen, Quanta Biosciences, Quidel, R-Biopharm Inc, Ribomed, Roche, Sacace Biotechnologies, Santacruz, Scientifix, Seegene, Seeplex, SensiGen, Serosep Ltd, Siemens, Sigma-Aldrich, Sigma-Genosys, SinaGen, Stratagene (Agilent), Synbiotics, Sysmex, Takara, Thermo Fisher, TiBMolBiol, Ventana (Roche), Vircell, Virion, vivantis, VWR, Zeiss, Zymo
Key Features
Enables suppliers to profile key areas of molecular diagnostics markets relating to their own products and services and provides qualified prospects by end-user organisation name 2) Analyses and ranks molecular diagnostics practices by country, organisation type, methods, diseases, clinical research areas, viruses, bacteria and others, helping suppliers to identify 'high opportunity' sectors relevant to their current molecular diagnostics products and future plans in these fields, supporting targeted marketing and reducing costs and risks 3) Provides key information in growing and developing areas of the molecular diagnostics market, helping suppliers focus resources on molecular diagnostics growth areas, supporting new sales opportunities in important market sectors 4) Helps suppliers to evolve and extend their own strategic visions, future plans and operational activities in the molecular diagnostics field 5) Enables suppliers to identify, analyse and rank end-user practices and needs and build new customer relationships in leading molecular diagnostics market sectors.
CHAPTER 1. MOLECULAR DIAGNOSTICS 2016
1.1 Conduct of study
1.2 Data Analysis
1.3 Study Data
CHAPTER 2. GLOBAL MOLECULAR DIAGNOSTICS
2.1 Global Regions
Figure 2.1. The global use of molecular diagnostics
Table 2.1. The global use of molecular diagnostics
Figure 2.2. The use of molecular diagnostics in North America
Table 2.2. The use of molecular diagnostics in North America
Figure 2.3. The use of molecular diagnostics in Europe
Table 2.3. The use of molecular diagnostics in Europe
Figure 2.4. The use of molecular diagnostics in Asia
Table 2.4. The use of molecular diagnostics in Asia
Figure 2.5. The use of molecular diagnostics in South America
Table 2.5. The use of molecular diagnostics in South America
Figure 2.6. The use of molecular diagnostics in Middle East
Table 2.6. The use of molecular diagnostics in Middle East
Figure 2.7. The use of molecular diagnostics in Oceania
Table 2.7. The use of molecular diagnostics in Oceania
Figure 2.8. The use of molecular diagnostics in Central America
Table 2.8. The use of molecular diagnostics in Central America
Figure 2.9. The use of molecular diagnostics in North Africa
Table 2.9. The use of molecular diagnostics in North Africa
2.2 Organisation Types
Figure 2.10. Organisation types
Table 2.10. Organisation types
2.3 Molecular Diagnostics Methods
Figure 2.11. Molecular diagnostics methods
Table 2.11. Molecular diagnostics methods
2.4 Molecular Diagnostics Utilities
Figure 2.12. Molecular diagnostics utilities
Table 2.12. Molecular diagnostics utilities
2.5 Molecular Diagnostics Clinical & Clinical Research
Figure 2.13. Clinical /clinical research use of molecular diagnostics
Table 2.13. Clinical/clinical research use of molecular diagnostics
2.6 Diseases
Figure 2.14. Molecular diagnostics disease areas
Table 2.14. Molecular diagnostics disease areas
2.7 Viruses by Molecular Diagnostics
Figure 2.15. Molecular diagnostics virus areas
Table 2.15. Molecular diagnostics virus areas
2.8 Bacteria by Molecular Diagnostics
Figure 2.16. Molecular diagnostics bacteria areas
Table 2.16. Molecular diagnostics bacteria areas
2.9 Nucleic Acids
Figure 2.17. Molecular diagnostics nucleic acid types
Table 2.17. Molecular diagnostics nucleic acid types
2.10 Departments
Figure 2.18. Molecular diagnostics departments
Table 2.18. Molecular diagnostics departments
2.11 Nucleic Acids
Figure 2.19. Molecular diagnostics departments
Table 2.19. Molecular diagnostics departments
2.12 Other Molecular Methods
Figure 2.20. Other methods
Table 2.20. Other methods
2.12 Conclusions
CHAPTER 3. MOLECULAR DIAGNOSTICS BY COUNTRY
3.1 Countries
Figure 3.1. Molecular diagnostics use by country
Table 3.1. Molecular diagnostics use by country
3.2 Organisation types
Figure 3.2. Molecular diagnostics organisation types
Table 3.2. Molecular diagnostics organisation types
3.3 Cities
Figure 3.3. Molecular diagnostics cities
Table 3.3. Molecular diagnostics cities
3.4 Molecular Diagnostics Methods
Figure 3.4. Molecular diagnostics methods
Table 3.4. Molecular diagnostics methods
3.5 Molecular Diagnostics Applications
Figure 3.5. Molecular diagnostics applications
Table 3.5. Molecular diagnostics applications
3.6 Clinical & Research
Figure 3.6. Clinical/clinical research molecular diagnostics
Table 3.6. Clinical/clinical research molecular diagnostics
3.7 Diseases
Figure 3.7. Molecular diagnostics disease areas
Table 3.7. Molecular diagnostics disease areas
3.8 Viruses
Figure 3.8. Molecular diagnostics viruses
Table 3.8. Molecular diagnostics virus areas
3.9 Bacteria
Figure 3.9. Molecular diagnostics bacteria
Table 3.9. Molecular diagnostics bacteria areas
3.10 Nucleic Acids
Figure 3.10. Molecular diagnostics nucleic acid types
Table 3.10. Molecular diagnostics nucleic acid types
3.11 Molecular Diagnostics Departments
Figure 3.11. Molecular diagnostics departments
Table 3.11. Molecular diagnostics departments
3.12 Other Methods
Figure 3.12. Other methods
Table 3.12. Other methods
3.13 Conclusions
CHAPTER 4. ORGANISATION TYPES
Figure 4.1. Molecular diagnostics by organisation types
Table 4.1. Molecular diagnostics by organisation types
4.2 Cities
Figure 4.2. Molecular diagnostics cities
Table 4.2. Molecular diagnostics cities
4.3 Molecular Diagnostics Methods
Figure 4.3. Molecular diagnostics methods
Table 4.3. Molecular diagnostics methods
4.4 Molecular Diagnostics Utilities
Figure 4.4. Molecular diagnostics applications
Table 4.4. Molecular diagnostics applications
4.5 Clinical & Research
Figure 4.5. Molecular diagnostics Clinical/clinical research
Table 4.5. Molecular diagnostics Clinical/clinical research
4.6 Diseases
Figure 4.6. Molecular diagnostics disease areas
Table 4.6. Molecular diagnostics disease areas
4.7 Viruses
Figure 4.7. Molecular diagnostics viruses
Table 4.7. Molecular diagnostics viruses
4.8 Bacteria
Figure 4.8. Molecular diagnostics bacteria
Table 4.8. Molecular diagnostics bacteria
4.9 Nucleic Acids
Figure 4.9. Molecular diagnostics nucleic acids
Table 4.9. Molecular diagnostics nucleic acids
4.10 Molecular Diagnostics Departments
Figure 4.10. Molecular diagnostics by end-user departments
Table 4.10. Molecular diagnostics by end-user departments
4.11 Other Methods
Figure 4.11. Other methods
Table 4.11. Other methods
4.12 Conclusions
CHAPTER 5. MOLECULAR DIAGNOSTICS BY USER DEPARTMENTS
Figure 5.1. Molecular diagnostics use by department
Table 5.1. Molecular diagnostics use by department
5.1 Organisation types
Figure 5.2. Molecular diagnostics organisations
Table 5.2. Molecular diagnostics organisations
5.2 States and Cities
Figure 5.3. Molecular diagnostics cities
Table 5.3. Molecular diagnostics cities
5.3 Methods
Figure 5.5. Molecular diagnostics methods
Table 5.5. Molecular diagnostics methods
5.4 Applications
Figure 5.5. Molecular diagnostics applications
Table 5.5. Molecular diagnostics applications
5.5 Clinical & Research
Figure 5.6. Molecular diagnostics Clinical/clinical research
Table 5.6. Molecular diagnostics Clinical/clinical research
5.6 Diseases
Figure 5.7. Molecular diagnostics disease areas
Table 5.7. Molecular diagnostics disease areas
5.7 Viruses
Figure 5.8. Molecular diagnostics viruses
Table 5.8. Molecular diagnostics viruses
5.8 Bacteria
Figure 5.9. Molecular diagnostics bacteria
Table 5.9. Molecular diagnostics bacteria
5.9 Nucleic Acids
Figure 5.10. Molecular diagnostics nucleic acids
Table 5.10. Molecular diagnostics nucleic acids
5.10 Other Methods
Figure 5.11. Other methods
Table 5.10. Other methods
5.11 Conclusions
CHAPTER 6. MOLECULAR DIAGNOSTICS METHODS
Figure 6.1. Molecular diagnostics methods
Table 6.1. Molecular diagnostics methods
6.1 Organisation types
Figure 6.2. Molecular diagnostics organisations
Table 6.2. Molecular diagnostics organisations
6.2 Countries
Figure 6.3. Molecular diagnostics countries
Table 6.3. Molecular diagnostics countries
6.3 Organisation types
Figure 6.4. Molecular diagnostics organisations
Table 6.4. Molecular diagnostics organisations
6.4 Cities
Figure 6.6. Molecular diagnostics cities
Table 6.6. Molecular diagnostics cities
6.5 Clinical & Research
Figure 6.6. Molecular diagnostics clinical/clinical research
Table 6.6. Molecular diagnostics clinical/clinical research
6.6 Diseases
Figure 6.7. Molecular diagnostics disease areas
Table 6.7. Molecular diagnostics disease areas
6.7 Viruses
Figure 6.8. Molecular diagnostics viruses
Table 6.8. Molecular diagnostics viruses
6.8 Bacteria
Figure 6.9. Molecular diagnostics bacteria
Table 6.9. Molecular diagnostics bacteria
6.9 Nucleic Acids
Figure 6.10. Molecular diagnostics nucleic acids
Table 6.10. Molecular diagnostics nucleic acids
6.10 Departments
Figure 6.11. Molecular diagnostics departments
Table 6.11. Molecular diagnostics departments
6.11 Other Methods
Figure 6.12. Other methods
Table 6.12. Other methods
6.12 Conclusions
CHAPTER 7. MOLECULAR DIAGNOSTICS APPLICATIONS
Figure 7.1. Molecular diagnostics applications
Table 7.1. Molecular diagnostics applications
7.1 Organisation types
Figure 7.2. Molecular diagnostics organisations
Table 7.2. Molecular diagnostics organisations
7.2 Cities
Figure 7.3. Molecular diagnostics cities
Table 7.3. Molecular diagnostics cities
7.3 Methods
Figure 7.4. Molecular diagnostics methods
Table 7.4. Molecular diagnostics methods
7.4 Clinical & Research
Figure 7.5. Clinical/clinical research
Table 7.5. Clinical/clinical research
7.5 Diseases
Figure 7.7. Molecular diagnostics disease areas
Table 7.7. Molecular diagnostics disease areas
7.6 Viruses
Figure 7.7. Molecular diagnostics viruses
Table 7.7. Molecular diagnostics viruses
7.7 Bacteria
Figure 7.8. Molecular diagnostics bacteria
Table 7.8. Molecular diagnostics bacteria
7.8 Nucleic Acids
Figure 7.9. Molecular diagnostics nucleic acids
Table 7.9. Molecular diagnostics nucleic acids
7.9 Departments
Figure 7.10. Molecular diagnostics departments
Table 7.10. Molecular diagnostics departments
7.10 Other Methods
Figure 7.11. Other methods
Table 7.11. Other methods
7.11 Conclusions
CHAPTER 8. DISEASE AREAS
Figure 8.1. Molecular diagnostics disease areas
Table 8.1. Molecular diagnostics disease areas
8.1 Organisation types
Figure 8.2. Molecular diagnostics organisations
Table 8.2. Molecular diagnostics organisations
8.1 Countries
Figure 8.3. Molecular diagnostics countries
Table 8.3. Molecular diagnostics countries
8.3 Cities
Figure 8.4. Molecular diagnostics cities
Table 8.4. Molecular diagnostics cities
8.4 Methods
Figure 8.5. Molecular diagnostics methods
Table 8.5. Molecular diagnostics methods
8.5 Applications
Figure 8.6. Molecular diagnostics application
Table 8.6. Molecular diagnostics application
8.6 Clinical & Research
Figure 8.8. Molecular diagnostics Clinical/clinical research
Table 8.8. Clinical/clinical research
8.7 Viruses
Figure 8.8. Molecular diagnostics viruses
Table 8.8. Molecular diagnostics viruses
8.8 Bacteria
Figure 8.9. Molecular diagnostics bacteria
Table 8.9. Molecular diagnostics bacteria
8.9 Nucleic Acids
Figure 8.10. Molecular diagnostics nucleic acids
Table 8.10. Molecular diagnostics nucleic acids
8.10 Departments
Figure 8.11. Molecular diagnostics departments
Table 8.11. Molecular diagnostics departments
8.11 Other Methods
Figure 8.12. Other methods
Table 8.12. Molecular diagnostics methods
8.12 Conclusions
CHAPTER 9. VIRUSES
Figure 9.1. Molecular diagnostics viruses
Table 9.1. Molecular diagnostics viruses
9.1 Organisation types
Figure 9.2. Molecular diagnostics organisations
Table 9.2. Molecular diagnostics organisations
9.2 Cities
Figure 9.3. Molecular diagnostics cities
Table 9.3. Molecular diagnostics cities
9.3 Methods
Figure 9.4. Molecular diagnostics methods
Table 9.4. Molecular diagnostics methods
9.4 Applications
Figure 9.5. Molecular diagnostics applications
Table 9.5. Molecular diagnostics applications
9.5 Clinical & Research
Figure 9.6. Clinical/clinical research
Table 9.6. Clinical/clinical research
9.6 Diseases
Figure 9.7. Molecular diagnostics disease areas
Table 9.7. Molecular diagnostics disease areas
9.7 Bacteria
Figure 9.9. Molecular diagnostics bacteria
Table 9.9. Molecular diagnostics bacteria
9.8 Nucleic Acids
Figure 9.9. Molecular diagnostics nucleic acids
Table 9.9. Molecular diagnostics nucleic acids
9.9 Departments
Figure 9.10. Molecular diagnostics departments
Table 9.10. Molecular diagnostics departments
9.10 Other Methods
Figure 9.11. Other methods
Table 9.11. Other methods
9.11 Conclusions
CHAPTER 10. BACTERIA
Figure 10.1. Molecular diagnostics viruses
Table 10.1. Molecular diagnostics viruses
10.1 Countries
Figure 10.2. Molecular diagnostics countries
Table 10.2. Molecular diagnostics countries
10.2 Organisation types
Figure 10.3 Organisation types
Table 10.3. Organisation types
10.3 Cities
Figure 10.4. Molecular diagnostics cities
Table 10.4. Molecular diagnostics cities
10.4 Methods
Figure 10.5. Molecular diagnostics methods
Table 10.5. Molecular diagnostics methods
10.5 Applications
Figure 10.6. Molecular diagnostics applications
Table 10.6. Molecular diagnostics applications
10.6 Clinical & Research
Figure 10.7. Clinical/clinical research
Table 10.7. Clinical/clinical research
10.7 Diseases
Figure 10.8. Molecular diagnostics disease areas
Table 10.8. Molecular diagnostics disease areas
10.8 Viruses
Figure 10.10. Molecular diagnostics viruses
Table 10.10. Molecular diagnostics viruses
10.9 Nucleic Acids
Figure 10.10. Molecular diagnostics nucleic acids
Table 10.10. Molecular diagnostics nucleic acids
10.10 Departments
Figure 10.11. Molecular diagnostics departments
Table 10.11. Molecular diagnostics departments
10.11 Other Methods
Figure 10.12. Other methods
Table 10.12. Other methods
10.12 Conclusions
CHAPTER 11. CLINICAL AND CLINICAL RESEARCH
Figure 11.1. Clinical
Table 11.1. Clinical
Figure 11.2. Research
Table 11.2. Research
11.1 Countries
Figure 11.3. Molecular diagnostics countries
Table 11.3. Molecular diagnostics countries
Figure 11.4. Molecular diagnostics countries
Table 11.4. Molecular diagnostics countries
11.2 Organisation types
Figure 11.5. Molecular diagnostics organisation types
Table 11.5. Molecular diagnostics organisation types
Figure 11.6. Molecular diagnostics organisation types
Table 11.6. Molecular diagnostics organisation types
11.3 Cities
Figure 11.7. Molecular diagnostics cities
Table 11.7. Molecular diagnostics cities
Figure 11.8. Molecular diagnostics cities
Table 11.8. Molecular diagnostics cities
11.4 Methods
Figure 11.9. Molecular diagnostics methods
Table 11.9. Molecular diagnostics methods
Figure 11.11. Molecular diagnostics methods
Table 11.11. Molecular diagnostics methods
11.5 Applications
Figure 11.11. Molecular diagnostics applications
Table 11.11. Molecular diagnostics applications
Figure 11.12. Molecular diagnostics applications
Table 11.12. Molecular diagnostics applications
11.6 Diseases
Figure 11.13. Molecular diagnostics diseases
Table 11.13. Molecular diagnostics diseases
Figure 11.14. Molecular diagnostics diseases
Table 11.14. Molecular diagnostics diseases
11.7 Viruses
Figure 11.15. Molecular diagnostics viruses
Table 11.15. Molecular diagnostics viruses
Figure 11.16. Molecular diagnostics viruses
Table 11.16. Molecular diagnostics viruses
11.8 Bacteria
Figure 11.17. Molecular diagnostics bacteria
Table 11.17. Molecular diagnostics bacteria
Figure 11.18. Molecular diagnostics bacteria
Table 11.18. Molecular diagnostics bacteria
11.9 Nucleic Acids
Figure 11.19. Molecular diagnostics nucleic acids
Table 11.19. Molecular diagnostics nucleic acids
Figure 11.20. Molecular diagnostics nucleic acids
Table 11.20. Molecular diagnostics nucleic acids
11.10 Departments
Figure 11.21. Molecular diagnostics departments
Table 11.21. Molecular diagnostics departments
Figure 11.22. Molecular diagnostics departments
Table 11.22. Molecular diagnostics departments
11.11 Other Methods
Figure 11.23. Other methods
Table 11.23. Other methods
Figure 11.24. Other methods
Table 11.24. Other methods
11.12 Conclusions
CHAPTER 12. NUCLEIC ACIDS
Figure 12.1. Molecular diagnostics nucleic acids
Table 12.1. Molecular diagnostics nucleic acids
12.1 Countries
Figure 12.2. Molecular diagnostics countries
Table 12.2. Molecular diagnostics countries
12.2 Organisation types
Figure 12.3. Molecular diagnostics organisation types
Table 12.3. Molecular diagnostics organisation types
12.3 Cities
Figure 12.4. Molecular diagnostics cities
Table 12.4. Molecular diagnostics cities types
12.4 Methods
Figure 12.5. Molecular diagnostics methods
Table 12.5. Molecular diagnostics methods
12.5 Applications
Figure 12.6. Molecular diagnostics applications
Table 12.6. Molecular diagnostics applications
12.6 Clinical & Research
Figure 12.7. Clinical/clinical research
Table 12.7. Clinical/clinical research
12.7 Diseases
Figure 12.8. Molecular diagnostics disease areas
Table 12.8. Molecular diagnostics disease areas
12.8 Viruses
Figure 12.9. Molecular diagnostics viruses
Table 12.9. Molecular diagnostics viruses
12.9 Bacteria
Figure 12.10. Molecular diagnostics bacteria
Table 12.10. Molecular diagnostics bacteria
12.10 Nucleic Acids
Figure 12.12. Molecular diagnostics nucleic acids
Table 12.12. Molecular diagnostics nucleic acids
12.11 Departments
Figure 12.12. Molecular diagnostics departments
Table 12.12. Molecular diagnostics departments
12.12 Other Methods
Figure 12.13. Other molecular methods
Table 12.13. Other molecular methods
12.13 Conclusions
CHAPTER 13. OTHER MOLECULAR METHODS
Figure 13.1. Molecular diagnostics other methods
Table 13.1. Molecular diagnostics other methods
13.1 Countries
Figure 13.2. Molecular diagnostics countries
Table 13.2. Molecular diagnostics countries
13.2 Organisation types
Figure 13.3. Molecular diagnostics organisation types
Table 13.3. Molecular diagnostics organisation types
13.3 Cities
Figure 13.4. Molecular diagnostics cities
Table 13.4. Molecular diagnostics cities
13.4 Applications
Figure 13.5. Molecular diagnostics applications
Table 13.5. Molecular diagnostics applications
13.5 Clinical & Clinical Research
Figure 13.6. Molecular diagnostics cities
Table 13.6. Molecular diagnostics cities
13.6 Diseases
Figure 13.7. Molecular diagnostics disease areas
Table 13.7. Molecular diagnostics disease areas
13.7 Viruses
Figure 13.8. Molecular diagnostics viruses
Table 13.8. Molecular diagnostics viruses
13.8 Bacteria
Figure 13.9. Molecular diagnostics bacteria
Table 13.9. Molecular diagnostics bacteria
13.9 Nucleic Acids
Figure 13.10. Molecular diagnostics nucleic acids
Table 13.10. Molecular diagnostics nucleic acids
13.10 Departments
Figure 13.11. Molecular diagnostics departments
Table 13.11. Molecular diagnostics departments
13.11 Other Methods
Figure 13.13. Other molecular methods
Table 13.13. Other molecular methods
13.12 Conclusions
CHAPTER 14. DISCUSSION
14.1 Top Molecular Diagnostics Markets and Opportunities
14.2 Molecular Diagnostics Growth and Opportunities
14.3 Molecular Diagnostics Qualified Prospects and Opportunities
14.4 Molecular Diagnostics End-User Costs
14.5 Key Findings
1.1 Conduct of study
1.2 Data Analysis
1.3 Study Data
CHAPTER 2. GLOBAL MOLECULAR DIAGNOSTICS
2.1 Global Regions
Figure 2.1. The global use of molecular diagnostics
Table 2.1. The global use of molecular diagnostics
Figure 2.2. The use of molecular diagnostics in North America
Table 2.2. The use of molecular diagnostics in North America
Figure 2.3. The use of molecular diagnostics in Europe
Table 2.3. The use of molecular diagnostics in Europe
Figure 2.4. The use of molecular diagnostics in Asia
Table 2.4. The use of molecular diagnostics in Asia
Figure 2.5. The use of molecular diagnostics in South America
Table 2.5. The use of molecular diagnostics in South America
Figure 2.6. The use of molecular diagnostics in Middle East
Table 2.6. The use of molecular diagnostics in Middle East
Figure 2.7. The use of molecular diagnostics in Oceania
Table 2.7. The use of molecular diagnostics in Oceania
Figure 2.8. The use of molecular diagnostics in Central America
Table 2.8. The use of molecular diagnostics in Central America
Figure 2.9. The use of molecular diagnostics in North Africa
Table 2.9. The use of molecular diagnostics in North Africa
2.2 Organisation Types
Figure 2.10. Organisation types
Table 2.10. Organisation types
2.3 Molecular Diagnostics Methods
Figure 2.11. Molecular diagnostics methods
Table 2.11. Molecular diagnostics methods
2.4 Molecular Diagnostics Utilities
Figure 2.12. Molecular diagnostics utilities
Table 2.12. Molecular diagnostics utilities
2.5 Molecular Diagnostics Clinical & Clinical Research
Figure 2.13. Clinical /clinical research use of molecular diagnostics
Table 2.13. Clinical/clinical research use of molecular diagnostics
2.6 Diseases
Figure 2.14. Molecular diagnostics disease areas
Table 2.14. Molecular diagnostics disease areas
2.7 Viruses by Molecular Diagnostics
Figure 2.15. Molecular diagnostics virus areas
Table 2.15. Molecular diagnostics virus areas
2.8 Bacteria by Molecular Diagnostics
Figure 2.16. Molecular diagnostics bacteria areas
Table 2.16. Molecular diagnostics bacteria areas
2.9 Nucleic Acids
Figure 2.17. Molecular diagnostics nucleic acid types
Table 2.17. Molecular diagnostics nucleic acid types
2.10 Departments
Figure 2.18. Molecular diagnostics departments
Table 2.18. Molecular diagnostics departments
2.11 Nucleic Acids
Figure 2.19. Molecular diagnostics departments
Table 2.19. Molecular diagnostics departments
2.12 Other Molecular Methods
Figure 2.20. Other methods
Table 2.20. Other methods
2.12 Conclusions
CHAPTER 3. MOLECULAR DIAGNOSTICS BY COUNTRY
3.1 Countries
Figure 3.1. Molecular diagnostics use by country
Table 3.1. Molecular diagnostics use by country
3.2 Organisation types
Figure 3.2. Molecular diagnostics organisation types
Table 3.2. Molecular diagnostics organisation types
3.3 Cities
Figure 3.3. Molecular diagnostics cities
Table 3.3. Molecular diagnostics cities
3.4 Molecular Diagnostics Methods
Figure 3.4. Molecular diagnostics methods
Table 3.4. Molecular diagnostics methods
3.5 Molecular Diagnostics Applications
Figure 3.5. Molecular diagnostics applications
Table 3.5. Molecular diagnostics applications
3.6 Clinical & Research
Figure 3.6. Clinical/clinical research molecular diagnostics
Table 3.6. Clinical/clinical research molecular diagnostics
3.7 Diseases
Figure 3.7. Molecular diagnostics disease areas
Table 3.7. Molecular diagnostics disease areas
3.8 Viruses
Figure 3.8. Molecular diagnostics viruses
Table 3.8. Molecular diagnostics virus areas
3.9 Bacteria
Figure 3.9. Molecular diagnostics bacteria
Table 3.9. Molecular diagnostics bacteria areas
3.10 Nucleic Acids
Figure 3.10. Molecular diagnostics nucleic acid types
Table 3.10. Molecular diagnostics nucleic acid types
3.11 Molecular Diagnostics Departments
Figure 3.11. Molecular diagnostics departments
Table 3.11. Molecular diagnostics departments
3.12 Other Methods
Figure 3.12. Other methods
Table 3.12. Other methods
3.13 Conclusions
CHAPTER 4. ORGANISATION TYPES
Figure 4.1. Molecular diagnostics by organisation types
Table 4.1. Molecular diagnostics by organisation types
4.2 Cities
Figure 4.2. Molecular diagnostics cities
Table 4.2. Molecular diagnostics cities
4.3 Molecular Diagnostics Methods
Figure 4.3. Molecular diagnostics methods
Table 4.3. Molecular diagnostics methods
4.4 Molecular Diagnostics Utilities
Figure 4.4. Molecular diagnostics applications
Table 4.4. Molecular diagnostics applications
4.5 Clinical & Research
Figure 4.5. Molecular diagnostics Clinical/clinical research
Table 4.5. Molecular diagnostics Clinical/clinical research
4.6 Diseases
Figure 4.6. Molecular diagnostics disease areas
Table 4.6. Molecular diagnostics disease areas
4.7 Viruses
Figure 4.7. Molecular diagnostics viruses
Table 4.7. Molecular diagnostics viruses
4.8 Bacteria
Figure 4.8. Molecular diagnostics bacteria
Table 4.8. Molecular diagnostics bacteria
4.9 Nucleic Acids
Figure 4.9. Molecular diagnostics nucleic acids
Table 4.9. Molecular diagnostics nucleic acids
4.10 Molecular Diagnostics Departments
Figure 4.10. Molecular diagnostics by end-user departments
Table 4.10. Molecular diagnostics by end-user departments
4.11 Other Methods
Figure 4.11. Other methods
Table 4.11. Other methods
4.12 Conclusions
CHAPTER 5. MOLECULAR DIAGNOSTICS BY USER DEPARTMENTS
Figure 5.1. Molecular diagnostics use by department
Table 5.1. Molecular diagnostics use by department
5.1 Organisation types
Figure 5.2. Molecular diagnostics organisations
Table 5.2. Molecular diagnostics organisations
5.2 States and Cities
Figure 5.3. Molecular diagnostics cities
Table 5.3. Molecular diagnostics cities
5.3 Methods
Figure 5.5. Molecular diagnostics methods
Table 5.5. Molecular diagnostics methods
5.4 Applications
Figure 5.5. Molecular diagnostics applications
Table 5.5. Molecular diagnostics applications
5.5 Clinical & Research
Figure 5.6. Molecular diagnostics Clinical/clinical research
Table 5.6. Molecular diagnostics Clinical/clinical research
5.6 Diseases
Figure 5.7. Molecular diagnostics disease areas
Table 5.7. Molecular diagnostics disease areas
5.7 Viruses
Figure 5.8. Molecular diagnostics viruses
Table 5.8. Molecular diagnostics viruses
5.8 Bacteria
Figure 5.9. Molecular diagnostics bacteria
Table 5.9. Molecular diagnostics bacteria
5.9 Nucleic Acids
Figure 5.10. Molecular diagnostics nucleic acids
Table 5.10. Molecular diagnostics nucleic acids
5.10 Other Methods
Figure 5.11. Other methods
Table 5.10. Other methods
5.11 Conclusions
CHAPTER 6. MOLECULAR DIAGNOSTICS METHODS
Figure 6.1. Molecular diagnostics methods
Table 6.1. Molecular diagnostics methods
6.1 Organisation types
Figure 6.2. Molecular diagnostics organisations
Table 6.2. Molecular diagnostics organisations
6.2 Countries
Figure 6.3. Molecular diagnostics countries
Table 6.3. Molecular diagnostics countries
6.3 Organisation types
Figure 6.4. Molecular diagnostics organisations
Table 6.4. Molecular diagnostics organisations
6.4 Cities
Figure 6.6. Molecular diagnostics cities
Table 6.6. Molecular diagnostics cities
6.5 Clinical & Research
Figure 6.6. Molecular diagnostics clinical/clinical research
Table 6.6. Molecular diagnostics clinical/clinical research
6.6 Diseases
Figure 6.7. Molecular diagnostics disease areas
Table 6.7. Molecular diagnostics disease areas
6.7 Viruses
Figure 6.8. Molecular diagnostics viruses
Table 6.8. Molecular diagnostics viruses
6.8 Bacteria
Figure 6.9. Molecular diagnostics bacteria
Table 6.9. Molecular diagnostics bacteria
6.9 Nucleic Acids
Figure 6.10. Molecular diagnostics nucleic acids
Table 6.10. Molecular diagnostics nucleic acids
6.10 Departments
Figure 6.11. Molecular diagnostics departments
Table 6.11. Molecular diagnostics departments
6.11 Other Methods
Figure 6.12. Other methods
Table 6.12. Other methods
6.12 Conclusions
CHAPTER 7. MOLECULAR DIAGNOSTICS APPLICATIONS
Figure 7.1. Molecular diagnostics applications
Table 7.1. Molecular diagnostics applications
7.1 Organisation types
Figure 7.2. Molecular diagnostics organisations
Table 7.2. Molecular diagnostics organisations
7.2 Cities
Figure 7.3. Molecular diagnostics cities
Table 7.3. Molecular diagnostics cities
7.3 Methods
Figure 7.4. Molecular diagnostics methods
Table 7.4. Molecular diagnostics methods
7.4 Clinical & Research
Figure 7.5. Clinical/clinical research
Table 7.5. Clinical/clinical research
7.5 Diseases
Figure 7.7. Molecular diagnostics disease areas
Table 7.7. Molecular diagnostics disease areas
7.6 Viruses
Figure 7.7. Molecular diagnostics viruses
Table 7.7. Molecular diagnostics viruses
7.7 Bacteria
Figure 7.8. Molecular diagnostics bacteria
Table 7.8. Molecular diagnostics bacteria
7.8 Nucleic Acids
Figure 7.9. Molecular diagnostics nucleic acids
Table 7.9. Molecular diagnostics nucleic acids
7.9 Departments
Figure 7.10. Molecular diagnostics departments
Table 7.10. Molecular diagnostics departments
7.10 Other Methods
Figure 7.11. Other methods
Table 7.11. Other methods
7.11 Conclusions
CHAPTER 8. DISEASE AREAS
Figure 8.1. Molecular diagnostics disease areas
Table 8.1. Molecular diagnostics disease areas
8.1 Organisation types
Figure 8.2. Molecular diagnostics organisations
Table 8.2. Molecular diagnostics organisations
8.1 Countries
Figure 8.3. Molecular diagnostics countries
Table 8.3. Molecular diagnostics countries
8.3 Cities
Figure 8.4. Molecular diagnostics cities
Table 8.4. Molecular diagnostics cities
8.4 Methods
Figure 8.5. Molecular diagnostics methods
Table 8.5. Molecular diagnostics methods
8.5 Applications
Figure 8.6. Molecular diagnostics application
Table 8.6. Molecular diagnostics application
8.6 Clinical & Research
Figure 8.8. Molecular diagnostics Clinical/clinical research
Table 8.8. Clinical/clinical research
8.7 Viruses
Figure 8.8. Molecular diagnostics viruses
Table 8.8. Molecular diagnostics viruses
8.8 Bacteria
Figure 8.9. Molecular diagnostics bacteria
Table 8.9. Molecular diagnostics bacteria
8.9 Nucleic Acids
Figure 8.10. Molecular diagnostics nucleic acids
Table 8.10. Molecular diagnostics nucleic acids
8.10 Departments
Figure 8.11. Molecular diagnostics departments
Table 8.11. Molecular diagnostics departments
8.11 Other Methods
Figure 8.12. Other methods
Table 8.12. Molecular diagnostics methods
8.12 Conclusions
CHAPTER 9. VIRUSES
Figure 9.1. Molecular diagnostics viruses
Table 9.1. Molecular diagnostics viruses
9.1 Organisation types
Figure 9.2. Molecular diagnostics organisations
Table 9.2. Molecular diagnostics organisations
9.2 Cities
Figure 9.3. Molecular diagnostics cities
Table 9.3. Molecular diagnostics cities
9.3 Methods
Figure 9.4. Molecular diagnostics methods
Table 9.4. Molecular diagnostics methods
9.4 Applications
Figure 9.5. Molecular diagnostics applications
Table 9.5. Molecular diagnostics applications
9.5 Clinical & Research
Figure 9.6. Clinical/clinical research
Table 9.6. Clinical/clinical research
9.6 Diseases
Figure 9.7. Molecular diagnostics disease areas
Table 9.7. Molecular diagnostics disease areas
9.7 Bacteria
Figure 9.9. Molecular diagnostics bacteria
Table 9.9. Molecular diagnostics bacteria
9.8 Nucleic Acids
Figure 9.9. Molecular diagnostics nucleic acids
Table 9.9. Molecular diagnostics nucleic acids
9.9 Departments
Figure 9.10. Molecular diagnostics departments
Table 9.10. Molecular diagnostics departments
9.10 Other Methods
Figure 9.11. Other methods
Table 9.11. Other methods
9.11 Conclusions
CHAPTER 10. BACTERIA
Figure 10.1. Molecular diagnostics viruses
Table 10.1. Molecular diagnostics viruses
10.1 Countries
Figure 10.2. Molecular diagnostics countries
Table 10.2. Molecular diagnostics countries
10.2 Organisation types
Figure 10.3 Organisation types
Table 10.3. Organisation types
10.3 Cities
Figure 10.4. Molecular diagnostics cities
Table 10.4. Molecular diagnostics cities
10.4 Methods
Figure 10.5. Molecular diagnostics methods
Table 10.5. Molecular diagnostics methods
10.5 Applications
Figure 10.6. Molecular diagnostics applications
Table 10.6. Molecular diagnostics applications
10.6 Clinical & Research
Figure 10.7. Clinical/clinical research
Table 10.7. Clinical/clinical research
10.7 Diseases
Figure 10.8. Molecular diagnostics disease areas
Table 10.8. Molecular diagnostics disease areas
10.8 Viruses
Figure 10.10. Molecular diagnostics viruses
Table 10.10. Molecular diagnostics viruses
10.9 Nucleic Acids
Figure 10.10. Molecular diagnostics nucleic acids
Table 10.10. Molecular diagnostics nucleic acids
10.10 Departments
Figure 10.11. Molecular diagnostics departments
Table 10.11. Molecular diagnostics departments
10.11 Other Methods
Figure 10.12. Other methods
Table 10.12. Other methods
10.12 Conclusions
CHAPTER 11. CLINICAL AND CLINICAL RESEARCH
Figure 11.1. Clinical
Table 11.1. Clinical
Figure 11.2. Research
Table 11.2. Research
11.1 Countries
Figure 11.3. Molecular diagnostics countries
Table 11.3. Molecular diagnostics countries
Figure 11.4. Molecular diagnostics countries
Table 11.4. Molecular diagnostics countries
11.2 Organisation types
Figure 11.5. Molecular diagnostics organisation types
Table 11.5. Molecular diagnostics organisation types
Figure 11.6. Molecular diagnostics organisation types
Table 11.6. Molecular diagnostics organisation types
11.3 Cities
Figure 11.7. Molecular diagnostics cities
Table 11.7. Molecular diagnostics cities
Figure 11.8. Molecular diagnostics cities
Table 11.8. Molecular diagnostics cities
11.4 Methods
Figure 11.9. Molecular diagnostics methods
Table 11.9. Molecular diagnostics methods
Figure 11.11. Molecular diagnostics methods
Table 11.11. Molecular diagnostics methods
11.5 Applications
Figure 11.11. Molecular diagnostics applications
Table 11.11. Molecular diagnostics applications
Figure 11.12. Molecular diagnostics applications
Table 11.12. Molecular diagnostics applications
11.6 Diseases
Figure 11.13. Molecular diagnostics diseases
Table 11.13. Molecular diagnostics diseases
Figure 11.14. Molecular diagnostics diseases
Table 11.14. Molecular diagnostics diseases
11.7 Viruses
Figure 11.15. Molecular diagnostics viruses
Table 11.15. Molecular diagnostics viruses
Figure 11.16. Molecular diagnostics viruses
Table 11.16. Molecular diagnostics viruses
11.8 Bacteria
Figure 11.17. Molecular diagnostics bacteria
Table 11.17. Molecular diagnostics bacteria
Figure 11.18. Molecular diagnostics bacteria
Table 11.18. Molecular diagnostics bacteria
11.9 Nucleic Acids
Figure 11.19. Molecular diagnostics nucleic acids
Table 11.19. Molecular diagnostics nucleic acids
Figure 11.20. Molecular diagnostics nucleic acids
Table 11.20. Molecular diagnostics nucleic acids
11.10 Departments
Figure 11.21. Molecular diagnostics departments
Table 11.21. Molecular diagnostics departments
Figure 11.22. Molecular diagnostics departments
Table 11.22. Molecular diagnostics departments
11.11 Other Methods
Figure 11.23. Other methods
Table 11.23. Other methods
Figure 11.24. Other methods
Table 11.24. Other methods
11.12 Conclusions
CHAPTER 12. NUCLEIC ACIDS
Figure 12.1. Molecular diagnostics nucleic acids
Table 12.1. Molecular diagnostics nucleic acids
12.1 Countries
Figure 12.2. Molecular diagnostics countries
Table 12.2. Molecular diagnostics countries
12.2 Organisation types
Figure 12.3. Molecular diagnostics organisation types
Table 12.3. Molecular diagnostics organisation types
12.3 Cities
Figure 12.4. Molecular diagnostics cities
Table 12.4. Molecular diagnostics cities types
12.4 Methods
Figure 12.5. Molecular diagnostics methods
Table 12.5. Molecular diagnostics methods
12.5 Applications
Figure 12.6. Molecular diagnostics applications
Table 12.6. Molecular diagnostics applications
12.6 Clinical & Research
Figure 12.7. Clinical/clinical research
Table 12.7. Clinical/clinical research
12.7 Diseases
Figure 12.8. Molecular diagnostics disease areas
Table 12.8. Molecular diagnostics disease areas
12.8 Viruses
Figure 12.9. Molecular diagnostics viruses
Table 12.9. Molecular diagnostics viruses
12.9 Bacteria
Figure 12.10. Molecular diagnostics bacteria
Table 12.10. Molecular diagnostics bacteria
12.10 Nucleic Acids
Figure 12.12. Molecular diagnostics nucleic acids
Table 12.12. Molecular diagnostics nucleic acids
12.11 Departments
Figure 12.12. Molecular diagnostics departments
Table 12.12. Molecular diagnostics departments
12.12 Other Methods
Figure 12.13. Other molecular methods
Table 12.13. Other molecular methods
12.13 Conclusions
CHAPTER 13. OTHER MOLECULAR METHODS
Figure 13.1. Molecular diagnostics other methods
Table 13.1. Molecular diagnostics other methods
13.1 Countries
Figure 13.2. Molecular diagnostics countries
Table 13.2. Molecular diagnostics countries
13.2 Organisation types
Figure 13.3. Molecular diagnostics organisation types
Table 13.3. Molecular diagnostics organisation types
13.3 Cities
Figure 13.4. Molecular diagnostics cities
Table 13.4. Molecular diagnostics cities
13.4 Applications
Figure 13.5. Molecular diagnostics applications
Table 13.5. Molecular diagnostics applications
13.5 Clinical & Clinical Research
Figure 13.6. Molecular diagnostics cities
Table 13.6. Molecular diagnostics cities
13.6 Diseases
Figure 13.7. Molecular diagnostics disease areas
Table 13.7. Molecular diagnostics disease areas
13.7 Viruses
Figure 13.8. Molecular diagnostics viruses
Table 13.8. Molecular diagnostics viruses
13.8 Bacteria
Figure 13.9. Molecular diagnostics bacteria
Table 13.9. Molecular diagnostics bacteria
13.9 Nucleic Acids
Figure 13.10. Molecular diagnostics nucleic acids
Table 13.10. Molecular diagnostics nucleic acids
13.10 Departments
Figure 13.11. Molecular diagnostics departments
Table 13.11. Molecular diagnostics departments
13.11 Other Methods
Figure 13.13. Other molecular methods
Table 13.13. Other molecular methods
13.12 Conclusions
CHAPTER 14. DISCUSSION
14.1 Top Molecular Diagnostics Markets and Opportunities
14.2 Molecular Diagnostics Growth and Opportunities
14.3 Molecular Diagnostics Qualified Prospects and Opportunities
14.4 Molecular Diagnostics End-User Costs
14.5 Key Findings
